qualifications for glp-1 Blog | Discover Your Weight Journey—Get Informed — Navigate Weight & Metabolic Free Handout: 8 Great Ways
Description
No changes in effect sizes were observed when excluding individuals with chronic kidney disease, previous pancreatitis and previous falls
Research has shown that individuals who stay on GLP-1s for an extended period (68 weeks or more) can achieve significant weight loss and maintain their results
GLP-1s Approved in Europe (Wegovy, Saxenda, Mounjaro)GLP-1s Approved in Europe (Wegovy, Saxenda, Mounjaro) Several GLP-1 medicines are now approved in Europe to help with weight management
Most inventory is likely to be for 2nd or 3rd brands launched by cos - which is not targeting the core (Starting) Endo / cardiac docs E) this is a subcutaneous Inj and not an IV - very easy to take on your own and at home
It is also FDA approved to treat moderate to severe obstructive sleep apnea in adults with obesity
